Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products ProductsPipeline NewsCipher Pharmaceuticals Provides Update on Absorica Brand Extension Program with Sun Pharmaceutical February 6, 2020Cipher Pharmaceuticals Receives Notice of Termination from Bausch January 20, 2020Events Q3 2019 Results Conference Call/Webcast Replay Thursday, November 7, 2019 Webcast Investors Financial Reports Investor Presentation Corporate Governance Documents Webcasts
